Acadian Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.8M | Buy |
644,571
+477,072
| +285% | +$13.2M | 0.04% | 334 |
|
|
2025
Q1 | $4.75M | Buy |
167,499
+126,961
| +313% | +$3.6M | 0.01% | 516 |
|
|
2024
Q4 | $1.68M | Buy |
+40,538
| New | +$1.68M | ﹤0.01% | 808 |
|
|
2024
Q3 | – | Sell |
-7,585
| Closed | -$900K | – | 2255 |
|
|
2024
Q2 | $900K | Buy |
+7,585
| New | +$900K | ﹤0.01% | 1030 |
|
|
2024
Q1 | – | Sell |
-4,603
| Closed | -$457K | – | 1707 |
|
|
2023
Q4 | $457K | Buy |
4,603
+3,881
| +538% | +$385K | ﹤0.01% | 1042 |
|
|
2023
Q3 | $74K | Sell |
722
-1,952
| -73% | -$200K | ﹤0.01% | 1361 |
|
|
2023
Q2 | $324K | Sell |
2,674
-1,706
| -39% | -$207K | ﹤0.01% | 1162 |
|
|
2023
Q1 | $672K | Buy |
4,380
+121
| +3% | +$18.6K | ﹤0.01% | 981 |
|
|
2022
Q4 | $764K | Sell |
4,259
-8,288
| -66% | -$1.49M | ﹤0.01% | 913 |
|
|
2022
Q3 | $1.48M | Buy |
12,547
+6,061
| +93% | +$715K | 0.01% | 706 |
|
|
2022
Q2 | $927K | Buy |
6,486
+26
| +0.4% | +$3.72K | ﹤0.01% | 838 |
|
|
2022
Q1 | $1.11M | Sell |
6,460
-1,291
| -17% | -$222K | ﹤0.01% | 807 |
|
|
2021
Q4 | $1.97M | Sell |
7,751
-2,691
| -26% | -$682K | 0.01% | 661 |
|
|
2021
Q3 | $4.02M | Sell |
10,442
-8,867
| -46% | -$3.41M | 0.02% | 509 |
|
|
2021
Q2 | $4.54M | Buy |
19,309
+11,415
| +145% | +$2.68M | 0.02% | 489 |
|
|
2021
Q1 | $1.03M | Buy |
7,894
+3,475
| +79% | +$455K | ﹤0.01% | 942 |
|
|
2020
Q4 | $461K | Hold |
4,419
| – | – | ﹤0.01% | 1258 |
|
|
2020
Q3 | $313K | Buy |
4,419
+1,193
| +37% | +$84.5K | ﹤0.01% | 1289 |
|
|
2020
Q2 | $208K | Buy |
+3,226
| New | +$208K | ﹤0.01% | 1472 |
|